clinical trial · NCT06977568
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
Pacira Pharmaceuticals, Inc·phase2·terminated·n = 1
Osteoarthritis of HipZilrettaTriamcinolone Acetonide
brief summary
The goal of this clinical trial is to evaluate an injection procedure for the investigational drug in people with Osteoarthritis of the Hip. The Sponsor is conducting this research to evaluate successful injections in the hip by using two different needle sizes.
started
Jul 25, 2025
primary completion
Oct 16, 2025
completion
Oct 16, 2025
last updated
Dec 22, 2025
official title
A Phase 2, Randomized, Open-Label, Two-Arm Study to Evaluate a Procedure for Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release (TCA-IR) in Subjects With Osteoarthritis of the Hip
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol